Patients with hard-to-treat cancers are desperate for new and better cancer drugs. The FDA's accelerated approval process is supposed to do that. Does it?
Do you trust the pharmaceutical industry to price medicines fairly, provide quality generic drugs and be honest? What happened this week to undermine trust?
Does it matter whether you eat breakfast or run out the door on an empty stomach? A new study suggests that breakfast eaters have less heart disease. Why?
How much time do you spend sitting on average? Chances are it's way too much and it's surprisingly bad for your health. How can you counteract the harm?
The FDA has finally called a halt to pelvic mesh. It has been used for transvaginal surgical repair of pelvic organ prolapse. What took the FDA so long?
Millions of people use marijuana. Many rely on cannabis for medical reasons such as nerve pain. People taking marijuana may need more anesthesia than usual.
There are new ARB recalls. Camber and Torrent Pharma companies are recalling large lots of losartan. How did this happen? A new carcinogen rears its head!
Why is FDA Commissioner Dr. Scott Gottlieb leaving the agency? A few weeks ago he stated unequivocally: "I'm not leaving." What happened to change his mind?
The pharmaceutical industry often justifies the high cost of medications by citing how much it spends on R&D. But what do clinical trials really cost? A new study answers that question.
Drug prices have been out of control for years but it took the 5000 percent increase in the cost of Daraprim to wake up the American public. What changed?